About Luke Reid

Dr Luke Reid is an experienced research and technology commercialisation executive. His deep knowledge in the biotechnology sector has underpinned Microba’s growth into a global biotech company delivering on it’s mission to improve human health with precision microbiome science. Dr Reid’s expertise in translational research, technology commercialisation, commercial partnerships, licensing and intellectual property management uniquely places him to lead Microba as Chief Executive Officer. Previously, Dr Reid was Associate Director at UniQuest Pty Ltd, one of the global leaders in commercialisation of university technology. Prior to UniQuest Dr Reid held roles working with the world’s leading developer of advanced plant genetics, Dupont Pioneer, and the world leader in bioinnovation of enzymes, proteins and microorganisms, Novozymes. Dr Reid holds a PhD in molecular biology from The University of Adelaide and a Bachelor of Science (Biotechnology (Hons)) from Flinders University.